Health Condition 1: M45- Ankylosing spondylitis
Conditions
Interventions
Intervention1: INDIVIDUALISED HOMOEOPATHIC MEDICINE: This study aims to evaluate the effect of individualized homoeopathic medicines administered in 50-millesimal (LM) potency on disease activity and
Sponsors
National Institute of Homoeopathy
Eligibility
Inclusion criteria
Inclusion criteria: Cases fulfilling the diagnostic criteria for Ankylosing Spondylitis (ICD 10 M45) according to the ASAS classification criteria for axial spondyloarthritis Patients aged 18 to 45 years Patients of all sexes religions and socio-economic backgrounds Patients who have not taken any conventional treatment for AS in the last 4 weeks Patients who are willing to give consent Patients who can read or understand either English Hindi or Bengali
Exclusion criteria
Exclusion criteria: Patients diagnosed with life-threatening diseases, uncontrolled systemic illnesses, immunocompromised states psychiatric disorders or malignancy Patients unwilling to undergo required investigations if needed Patients currently on NSAIDs DMARDs or biological therapy for AS Pregnant women and lactating mothers Patients with a history of substance abuse and/or dependence
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Bath Ankylosing Spondylitis Disease Activity Index BASDAI scores Timepoint: baseline to 6 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Ankylosing Spondylitis Quality of Life questionnaireTimepoint: baseline to 6 months | — |
Countries
India
Contacts
Public ContactProf Dr Subhas Singh
National Institute of Homoeopathy
Outcome results
None listed